Olaparib Maintenance Therapy in Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Olaparib|DRUG: Chemotherapy drug
Sponsor: National Taiwan University Hospital
Collaborators: AstraZeneca